Shareholders Equity: The sum of preferred and common equity items.
Achieve Life Sciences, Inc. (ACHV) had Shareholders Equity of $21.52M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-14.66M |
|
-- |
|
-- |
|
$14.73M |
|
$-14.73M |
|
$0.07M |
|
$-14.66M |
|
$-14.66M |
|
$-14.66M |
|
$-14.66M |
|
$-14.66M |
|
$-14.66M |
|
$-14.73M |
|
$-14.66M |
|
43.59M |
|
43.59M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$39.89M |
|
-- |
|
$1.90M |
|
$41.79M |
|
$9.08M |
|
$11.19M |
|
$11.19M |
|
$20.27M |
|
$21.52M |
|
$19.73M |
|
|
Shareholders Equity |
$21.52M |
53.23M |
|
| Cash Flow Statement Financials | |
$-49.47M |
|
$6.11M |
|
$51.53M |
|
$12.77M |
|
$20.95M |
|
$8.18M |
|
$8.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.39 |
|
-- |
|
-- |
|
0.34 |
|
0.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.14% |
|
-74.30% |
|
-35.09% |
|
-44.83% |
|
$0.40 |
|
$-1.13 |
|
$-1.13 |
|